WSMD2017 - Workshop on Schizophrenia and other Mental Disorders

from Thursday, 15 June 2017 (08:00) to Friday, 16 June 2017 (13:30)


        : Sessions
    /     : Talks
        : Breaks
15 Jun 2017
16 Jun 2017
AM
08:00 --- Registration ---
08:45 Welcome and introduction - Alberto Del Guerra (PI)   ()
09:00
Mental disorders: where do we stand? - Liliana Dell'Osso (University of Pisa) Alberto Del Guerra (PI) (until 10:00) ()
09:00 Current Trends in diagnosis and treatment of mental disorders - Silvana Galderisi (University of Campania)   ()
Slides
09:30 The FP7 and Horizon2020 funding strategy of projects on mental disorders - Francois Junique (EU-DG CONNECT) Lara Passante (EU-DG for Research and Innovation)   ()
Slides
10:00 --- Coffee break ---
10:30
Status of the FP7 and Horizon 2020 funded projects on mental disorders - Ubaldo Bonuccelli (Unoversity of Pisa) Silvana Galderisi (University of Campania) (until 13:30) ()
10:30 OPTIMISE: Optimization of Treatment and Management of Schizophrenia in Europe - Inge Winter-van Rossum (University of Utrecht)   ()
Slides
11:00 PRONIA: Personalised Prognostic Tools for Early Psychosis Management - Nikolaos Koutsouleris (Ludwig-Maximilians-Universität München)   ()
Slides
11:30 PSYSCAN: Translating neuroimaging findings from research into clinical practice - Philip McGuire (King's College London)   ()
Slides
12:00 TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia - Alberto Del Guerra (PI)   ()
Slides
12:30 MINDVIEW: Multimodal Imaging of Neurological Disorders - Jose Benlloch (University of Valencia)   ()
Slides
13:00 The view of the Pharmaceutical European Industry in Neuroscience - Luc Truyen (Johnson & Johnson)   ()
Slides
08:30
Neurodegenerative diseases and the Human Brain Project - Giovanni Cioni (University of Pisa (Italy)) Adriana Maggi (University of Milano (Italy)) (until 11:00) ()
08:30 Alzheimer’s Disease: Diagnosis, Prognosis and Current Therapy - Adriana Maggi (University of Milano (Italy))   ()
Slides
09:00 Parkinson disease within the conceptual framework of the new Geroscience - Claudio Franceschi (University of Bologna (Italy))   ()
09:30 7T MRI neuroimaging for neurodegenerative disorders - Mirco Cosottini (University of Pisa (Italy))   ()
Slides
10:00 Mortui vivos docent: Recent Advances on the Involvement of Synaptic Pathology in Schizophrenia - Sabina Berretta (Harvard Medical School (USA))   ()
Slides
10:30 The Human Brain Project: a Platform for Big-Data Neuroscience - Jan Bjaalie (University of Oslo (Norway))   ()
Slides
11:00 --- Coffee break ---
11:30
Panel discussion Future Coordination and integration of the results of the FP7 and IMI projects and HBP on Schizophrenia and other Mental Disorders - Nikolaos Koutsouleris (LMU München (Germany)) Laura Passante (EC (Belgium)) Elisabetta Vaudano (IMI (Belgium)) Jan Bjaalie (University of Oslo (Norway)) (until 13:30) ()
slides
PM
13:30 Lunch break   ()
14:30
Status of the FP7 and Horizon 2020 funded projects on mental disorders (continued) - Celso Arango (Gregorio Marañón Hospital) Paolo Brambilla (University of Milano) (until 17:00) ()
14:30 IMAGEMEND: IMAging GEnetics for MENtal Disorders - Giuseppe Blasi (University of Bari)   ()
Slides
15:00 BRAINTRAIN: Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders - David Linden (Cardiff University (UK))   ()
Slides
15:30 BIOCOG: Biomarker Development for Postoperative Cognitive Impairment in the Elderly - Georg Winterer Charité (Universitätsmedizin Berlin (Germany))   ()
Slides
16:00 METSY: Neuroimaging platform for characterisation of metabolic co-morbidities in psychotic disorders - Matej Oresic (University of Turku (Finland))   ()
Slides
16:30 LIFEBRAIN: Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts - Klaus P. Ebmeier (University of Oxford (UK))   ()
Slides
17:00 --- Coffee break ---
17:30
The IMI contribution in Brain studies - Carlo Altamura (University of Milano (Italy)) Karsten Heekeren (University of Zürich (Switzerland)) (until 19:00) ()
17:30 The IMI consortium and the IMI funded projects in Central Nervous System (CNS) - Elisabetta Vaudano (IMI)   ()
Slides
18:00 RADAR CNS: Use of Wearable Devices and Mobile Technology to Understand the Course of Brain Diseases - Nikolay Manyakov (Janssen Pharmaceuticals (Belgium))   ()
Slides
18:30 PRISM: Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer’s Disease, Schizophrenia, and Mayor Depression - Celso Arango (Gregorio Marañón Hospital (Spain))   ()
Slides